BOYLE J DAVID II 4
4 · AVI BIOPHARMA INC · Filed Apr 22, 2010
Insider Transaction Report
Form 4
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2010-04-20+50,000→ 50,000 totalExercise: $1.24From: 2010-04-20Exp: 2020-04-20→ Common Stock (50,000 underlying)
Holdings
- 247,932
Incentive Stock Option (right to buy)
Exercise: $1.21From: 2008-08-18Exp: 2018-08-18→ Common Stock (247,932 underlying) - 97,241
Incentive Stock Option (right to buy)
Exercise: $1.45From: 2011-02-09Exp: 2020-02-09→ Common Stock (97,241 underlying) - 82,759
Non-Qualified Stock Option (right to buy)
Exercise: $1.45From: 2011-02-09Exp: 2020-02-09→ Common Stock (82,759 underlying) - 50,000
Incentive Stock Option (right to buy)
Exercise: $0.92From: 2010-02-10Exp: 2019-02-10→ Common Stock (50,000 underlying) - 65,282
Common Stock
- 10,000
Incentive Stock Option (right to buy)
Exercise: $1.30From: 2011-03-09Exp: 2020-03-09→ Common Stock (10,000 underlying) - 90,000
Non-Qualified Stock Option (right to buy)
Exercise: $1.30From: 2011-03-09Exp: 2020-03-09→ Common Stock (90,000 underlying) - 100,000
Non-Qualified Stock Option (right to buy)
Exercise: $0.92From: 2010-02-10Exp: 2019-02-10→ Common Stock (100,000 underlying) - 102,068
Non-Qualified Stock Option (right to buy)
Exercise: $1.21From: 2008-08-18Exp: 2018-08-18→ Common Stock (102,068 underlying)
Footnotes (4)
- [F1]The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date.
- [F2]The options vest in equal annual installments over three years beginning on August 18, 2008.
- [F3]Grant vest 100% on grant date.
- [F4]Price not required on initial report of stock option granted.